Marjorie Fridkin, MD
Surgery · Oakland, MDNPI 1427129840
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Smith+Nephew at 24.6% of the total. Reporting peaked in 2021 at $136 and has fallen 87.8% since, to $17 in 2024. That places this record below the midpoint for surgery clinicians in MD, where the typical reported total is $976.
Across 14 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$60
- Organogenesis Inc.$40
- AbbVie$30
- Stryker$29
- Misonix Inc$28
- Bioventus LLC$25
- plus $31 from 2 others
What the payments were for
- Food & beverage$243100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 4 | $60 |
| Organogenesis Inc. | 3 | $40 |
| AbbVie | 2 | $30 |
| Stryker | 1 | $29 |
| Misonix Inc | 1 | $28 |
| Bioventus LLC | 1 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| Hartmann USA, Inc. | 1 | $14 |
How this compares
$243 in reported general payments places this provider in the 25th percentile of 493 surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 13 | $146 |
Paid to pharmacies, not to this prescriber.
Other surgery in Oakland
- Dorry SegevBaltimore$1.2M
- Thomas SwopeBaltimore$775K
- Alisa CokerBaltimore$702K
- Adrian ParkHagerstown$355K
- Igor BelyanskyAnnapolis$339K
- John LedonneBaltimore$329K
- Emad KandilOwings Mills$247K
- Martin MakaryBaltimore$135K
- Richard LuAnnapolis$116K
- Murtaza DawoodBaltimore$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.